The emerging buprenorphine epidemic in the United States

Journal of Addictive Diseases

Volumn 31, Issue 1, 2012, Pages 3-7

  Wish, Eric D ^a   Artigiani, Erin ^a   Billing, Amy ^a   Hauser, Wanda ^a   Hemberg, Jordana ^a   Shiplet, Myron ^b   DuPont, Robert L ^c  

^a UNIVERSITY OF MARYLAND   (United States)

^b FRIENDS Medical Laboratory Inc   (United States)

^c Institute for Behavior and Health Inc   (United States)

Author keywords

Buprenorphine misuse; Drug testing; Epidemic; Public health intervention

Indexed keywords

AMPHETAMINE; BENZODIAZEPINE; BUPRENORPHINE; BUPRENORPHINE PLUS NALOXONE; CANNABIS; COCAINE; CODEINE; DIAMORPHINE; HYDROCODONE; HYDROMORPHONE; LYSERGIDE; METHADONE; MORPHINE; OPIATE; OXYCODONE; OXYMORPHONE; PHENCYCLIDINE;

ARTICLE; CLINICAL LABORATORY; DRUG ABUSE; DRUG DEPENDENCE; DRUG FORMULATION; DRUG MISUSE; DRUG MONITORING; DRUG URINE LEVEL; EDUCATION PROGRAM; EMERGENCY TREATMENT; EPIDEMIC; FOOD AND DRUG ADMINISTRATION; FORENSIC TOXICOLOGY; HEALTH EDUCATION; HUMAN; LAW ENFORCEMENT; MAJOR CLINICAL STUDY; METHADONE TREATMENT; OPIATE ADDICTION; PHARMACY; PHYSICIAN; UNITED STATES; URINALYSIS;

ADULT; AGED; BALTIMORE; BUPRENORPHINE; FEMALE; HUMANS; MALE; MARYLAND; MIDDLE AGED; NARCOTIC ANTAGONISTS; OPIOID-RELATED DISORDERS; PILOT PROJECTS; STREET DRUGS; SUBSTANCE ABUSE DETECTION;

EID: 84858115478     PISSN: 10550887     EISSN: 15450848     Source Type: Journal    
DOI: 10.1080/10550887.2011.642757     Document Type: Article

References (12)

1. Lofwall M. Physicians' Clinical Support System for Buprenorphine (PCSS-B) hot topics in buprenorphine treatment webinars, June 14, 2011: minimizing the risks of buprenorphine diversion and misuse from office-based treatment. [Internet]. Arlington (VA): American Psychiatric Association, 2011 June 14 [reviewed 2011 June 14]. Online Webinar: 60 min. http:// www.psych.org / MainMenu / Psychiatric Practice / AddictionPsychiatry / Physicians% 20Clinical % 20Support % 20System % 20 Buprenorphine/APA-Sponsored-Webinars/June-14-2011- Presentation.aspx (accessed January 10, 2012).
2. U.S. Department of Justice, Drug Enforcement Agency (DEA), Office of Diversion Control. Automation of reports and consolidated orders system (ARCOS). http://www. deadiversion.usdoj.gov/arcos/index.html (accessed June 17, 2011).
3. Drug Abuse Warning Network. National estimates of drug-related emergency department visits, 2004-2009. http://www. samhsa.gov/data/DAWN.aspx#Dawn excel files (accessed January 10, 2012).
4. Drug Enforcement Administration, Office of Diversion Control, Drug and Chemical Evaluation Section. Buprenorphine (Trade Names: Buprenex®, Suboxone®, Subutex®) . www.deadiversion.usdoj.gov/ drugs concern/buprenorphine.pdf (accessed July 6, 2011).
5. Goodnough A, Zezima K. When children's scribbles hide a prison drug. New York Times. May 26, 2011. http://www. nytimes.com/2011/05/27/us/27smuggle. html? r = 1# (accessed July 6, 2011).
6. Hemingway, S. Suboxone succeeds in aiding opiate addicts, but too many are abusing it instead. Burlington Free Press. July 27, 2011. http://www.burlingtonfreepress. com/article/20110727/NEWS02/1107260 34 / Suboxone - succeeds - aiding - opiate - addicts-too-many-abusing-instead-? odyssey = tab # (accessed August 2, 2011).
7. Wish ED, O'Neil JA, Stevens R, et al. Urine testing for drug use amongmale arrestees-United States, 1989. MMWR Morb Mortal Wkly Rep 1989; 38(45):780-3.
8. DuPont RL, Wish ED. Operation tripwire revisited. Ann Am Acad Pol Soc Sci 1992; 521:91-111.
9. Wish ED. U.S. drug policy in the 1990s: insights from new data from arrestees. Int J Addict 1990-1991; 25(3A):377-409.
10. Stimmel B. Buprenorphine misuse, abuse, and diversion: when will we ever learn? J Addict Dis 2007; 26(3):1-3. (Pubitemid 47367822)
11. Agar M, Bourgois P, French J, Murdoch, O. Buprenorphine: "field trials" of a new drug. Qual Health Res 2001; 11(1):69-84. (Pubitemid 33707739)
12. Reckitt Benckiser Pharmaceuticals Inc. Highlights of prescribing information. http://www.suboxone.com/pdfs/Suboxone PI.pdf (accessed July 6, 2011).